life sciences
Three hires for RSA
October 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interim, life sciences, rsa
Life sciences executive search and interim management firm RSA has made three appointments to its European team. Elmar Scheuba has …
J&J partners with European biotech firms
October 4, 2013Research and Development, Sales and Marketing J&J, JJ, effimune, life sciences, merus
The London Johnson & Johnson Innovation Centre has teamed up with several biotech partners from the European region. Announced at …
UK life sciences gains £93 million backing
July 31, 2013Research and Development, Sales and Marketing BIA, DMD, life sciences
The UK life sciences sector has been given a new £93.2 million package of support by the government to help …
Life sciences to benefit from new UK budget plans
March 21, 2012Sales and Marketing ABPI, BIA, Budget, life sciences, tax
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …
Brinsmead to be life sciences adviser to government
November 23, 2010Sales and Marketing Brinsmead, NHS, government, life sciences
Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
UK science in line for £500m boost from EU
October 20, 2010Research and Development UK Biobank, UKCMRI, biotech funding, life sciences, science parks
The European Investment Bank has unveiled a £500 million package of loans to boost the UK’s science and education base …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2
August 26, 2010Research and Development Kinapse, White paper, life sciences, pharma
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1
August 11, 2010Research and Development Kinapse, life sciences, pharma
Valuations are essential components of effective transactions in the life sciences industry
What might the NHS white paper mean for Pharma commercial models?
July 16, 2010Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma
Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
